Douglas Lane & Associates’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14M Buy
44,349
+43,404
+4,593% +$13.7M 0.19% 111
2026
Q1
$311K Buy
945
+28
+3% +$10.1K ﹤0.01% 208
2025
Q4
$322K Sell
917
-81
-8% -$29.5K ﹤0.01% 200
2025
Q3
$369K Sell
998
-163
-14% -$63K 0.01% 195
2025
Q2
$459K Sell
1,161
-28
-2% -$10.5K 0.01% 181
2025
Q1
$443K Sell
1,189
-25
-2% -$9.51K 0.01% 189
2024
Q4
$437K Hold
1,214
0.01% 188
2024
Q3
$439K Buy
1,214
+350
+41% +$121K 0.01% 190
2024
Q2
$294K Buy
864
+292
+51% +$98.9K ﹤0.01% 207
2024
Q1
$205K Sell
572
-1,135
-66% -$382K ﹤0.01% 234
2023
Q4
$511K Sell
1,707
-178
-9% -$50K 0.01% 175
2023
Q3
$515K Buy
1,885
+74
+4% +$21.2K 0.01% 169
2023
Q2
$553K Sell
1,811
-180
-9% -$52K 0.01% 172
2023
Q1
$568K Sell
1,991
-130
-6% -$34.5K 0.01% 170
2022
Q4
$519K Sell
2,121
-29
-1% -$6.58K 0.01% 170
2022
Q3
$435K Buy
2,150
+20
+0.9% +$4.21K 0.01% 179
2022
Q2
$424K Hold
2,130
0.01% 184
2022
Q1
$569K Sell
2,130
-20
-0.9% -$5.18K 0.01% 172
2021
Q4
$575K Buy
2,150
+98
+5% +$25.7K 0.01% 173
2021
Q3
$541K Buy
2,052
+34
+2% +$9.09K 0.01% 168
2021
Q2
$524K Hold
2,018
0.01% 167
2021
Q1
$492K Buy
2,018
+6
+0.3% +$1.44K 0.01% 161
2020
Q4
$493K Sell
2,012
-65
-3% -$14.7K 0.01% 160
2020
Q3
$433K Hold
2,077
0.01% 162
2020
Q2
$374K Buy
2,077
+165
+9% +$30.4K 0.01% 169
2020
Q1
$318K Sell
1,912
-48
-2% -$9.38K 0.01% 172
2019
Q4
$411K Buy
1,960
+220
+13% +$45.7K 0.01% 173
2019
Q3
$376K Sell
1,740
-50
-3% -$10.7K 0.01% 176
2019
Q2
$368K Hold
1,790
0.01% 184
2019
Q1
$354K Sell
1,790
-41
-2% -$7.38K 0.01% 182
2018
Q4
$287K Buy
1,831
+100
+6% +$16.7K 0.01% 185
2018
Q3
$308K Buy
1,731
+111
+7% +$18.9K 0.01% 181
2018
Q2
$274K Sell
1,620
-150
-8% -$25.2K 0.01% 179
2018
Q1
$285K Sell
1,770
-100
-5% -$16.1K 0.01% 181
2017
Q4
$290K Buy
1,870
+30
+2% +$4.58K 0.01% 178
2017
Q3
$261K Sell
1,840
-25
-1% -$3.58K 0.01% 189
2017
Q2
$259K Sell
1,865
-235
-11% -$32.2K 0.01% 186
2017
Q1
$276K Sell
2,100
-528
-20% -$66.7K 0.01% 190
2016
Q4
$315K Sell
2,628
-292
-10% -$33.6K 0.01% 188
2016
Q3
$340K Sell
2,920
-25
-0.8% -$2.91K 0.01% 186
2016
Q2
$353K Buy
2,945
+20
+0.7% +$2.24K 0.01% 188
2016
Q1
$314K Buy
+2,925
New +$288K 0.01% 191

Other funds holding SYK

Douglas Lane & Associates's SYK Position: Q2 2026 in Review

Douglas Lane & Associates increased its Stryker (SYK) stake by 4,593% in Q2 2026, buying an estimated $13.7M and bringing the position to 44,349 shares worth $14M. The position accounts for 0.19% of the portfolio, ranked #111.

Douglas Lane & Associates first reported a position in SYK in Q1 2016 and has held it in 42 quarters since. 788 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Douglas Lane & Associates held 44,349 shares of Stryker worth $14M as of Q2 2026.
  • Douglas Lane & Associates bought 43,404 Stryker shares in Q2 2026, an estimated $13.7M.
  • Stryker made up 0.19% of Douglas Lane & Associates's portfolio in Q2 2026, its #111 holding.
  • Douglas Lane & Associates first reported a position in Stryker in Q1 2016 and has held it in 42 quarters since.
  • 788 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.